Breast apoptosis in physiology and pathology;L'apoptose mammaire dans le sein normal et en pathologie

References en Gynecologie Obstetrique

Volumn 6, Issue 1, 1999, Pages 33-40

  Desreux, J ^a   Goffin, F ^a   Beliard A ^a   Masson, V ^a   Noel A ^a   Kebers, F ^a   Thomas, J L ^b   Foidart, J M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b LaboratoiresTheramex Ctr Rech M

Author keywords

Apoptosis; Breast cancer; Fibroadenoma; Mammary; Menstrual cycle; Normal breast; Progestins; Programmed cell death

Indexed keywords

GESTAGEN; NOMEGESTROL ACETATE;

APOPTOSIS; BREAST CANCER; BREAST FIBROADENOMA; CARCINOGENESIS; CELL PROLIFERATION; HUMAN; MENSTRUAL CYCLE; REVIEW;

EID: 0033398707     PISSN: 12448168     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Thompson C. 1995 Apoptosis in the pathogenesis and treatment of disease Sci 267,1456-1462
2. Clarke PGH. 1990 Developmental cell death , morphological diversity and multiple mechanisms Acta Embryol 181,195-213
3. Hockenbery. 1995 Defining apoptosis (review). Am.J Pathol 146, 1,16-19
4. Stewart BW. 1994 Mechanisms of apoptosis , integration of genetic, biochemical and cellular indicators. J Natl Cancer Inst, 86, 17, 1286-1294
5. Majno G, and Joris I. 1995 Apoptosis, oncosis and necrosis (review) Am.J Pathol. 146, 1, 3-13
6. Stewart BW. 1994 Mechanisms of apoptosis , integration of genetic, biochemical and cellular indicators J Natl Cancer Inst, 86, 17, 1286-1294.
7. Sukharev S., Pleshakova O. and Sodavnikov V. 1997 Role of proteases in activation of apoptosis. Cell Death and Differentiation 4, 457-462
8. Salvesen G. and Dixit V. 1997 Caspases , intracellular signaling by proteolysis (minireview) Cell 91, 443-446.
9. Krajewska M, Wang H-G, Krajewski S et coll. 1997 Immunohistochemical analysis of in vivo patterns expression of CPP32 (Caspase-3), a cell death protease Cancer Res vol 57, 1605-1613
10. Jacobson M., Weil M. and Raff MC. 1997 Programmed cell death in animal development (review) Cell 88, 347-354
11. Thompson EB. 1994 Apoptosis and steroid hormones Mol Endo, vol.8, no 6, 665-673.
12. Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P and Welsh J-E. 1992 Active cell death in hormone dependent tissues Cancer Metast Rev, vol II, 197-200,-
13. Spencer SJ, Cataldo NA and Jaffe RB. 1996 Apoptosis in the human female reproductive tract. Obst Gyn Survey, vol 51, no 5, 314-323
14. Clerice M., Sarin A., Henkart P. and Shearer G. 1997 Apoptotic cell death and cytokine dysregulation in human immunodeficiency, virus infection pivotal factors in disease progression Cell Death and Differentiation 4, 699-706
15. Carson DA and Ribeiro JM. 1993 Apoptsosis and Disease The Lancet, vol 341, 1251-1254.
16. Isaacs JT. 1994 Advancies and controversies in the study of programmed cell death/apoptosis in the development and the therapy for cancer. Curr Opinion Oncol vol 6, 82-89
17. Bellamy C., Malcomson R., Harrison D. and Wyllie A. 1995 Cell death in health and disease the biology and regulation of apoptosis Cancer Biol 6 3-16
18. Mc Donnel T., Meyn R. and Robertson L. 1995 Implications of apoptotic cell death regulation in cancer therapy. Cancer Biol. 6, 53-60
19. Levine A. 1997 p53, the cellular gatekeeper growth and division (review). Cell 88, 323-331
20. Boudreau N, Sympson CJ, Werb Z and Bissel MJ. 1995 Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix Science , vol. 267, 891-893
21. Meredith JE, Fazeli JB and Schwartz MA. 1993 The extracellular matrix as a cell survival factor. Mol Biol Cell, vol 4, 953-961
22. Nagata S. 1997 Apoptosis by death factor (review). Cell 88, 355-365.
23. Craig R. 1995 The bcl-2 gene family. Cancer Biol. 6, 35-43
24. Orrenius S., Burgess D., Hampton M. and Zhivotovsky B. Mitochondria as the focus of apoptosis research (editorial). Cell Death and Differentiation 4, 427-428
25. Reed JC. 1994 Bcl-2 and the regulation of programmed cell death J Cell Biol , vol 124 1 and 2,1-6
26. Vogel PM, Georgiade NG, Fetter BF, Vogel FS and Mc Carty KS. 1981 The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol vol 104, no 1, 23-34.
27. Mauvais-Jarvis P, Kuttenn F, Malet C and Gompel A. 1986 Antiestrogen action of progesterone in breast tissue Breast Cancer Res Treatment, vol 8, 179-188
28. Ferguson DJP and Anderson TJ 1981 Morphological evaluation of cell turnover in relation to the menstrual cycle in the «resting» human breast. Br J Cancer vol 44, 177-187
29. Haslam SZ 1988 Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands Endocrinology vol 122, no 2, 464-470
30. Mark Cline J, Soderqvist G, Von Schoultz E, Lambert S and Von Schoultz B. 1996 Effect of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques Am J Obstet Gynecol vol 174, no 1, 93-100.
31. Masters RW, Drife JO, and Scaribrick JJ. 1977 Cyclic variation of DNA synthesis in human breast epithelium J Natl Cancer Inst vol 58, no 5, 1263-1265.
32. Sabourin J, Martin A, Baruch J et coll. 1994 Bcl-2 expression in normal human breast tissue during the menstrual cycle. Int J Cancer, vol 59, 1-6
33. Ferrières G., Cuny M., Simony-Lafontaine J. et coll. 1997 Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels , overexpression and absence of variation in fibroadenomas. J Pathol 183, 204-211
34. Soule HD and Mc Grath CM. 1986 A simplified method for passage and long term growth of human mammary epithelial cells. In Vitro Cell Dev Biol, vol 22, no 1, 6-12
35. Gavrieli Y, Sherman Y and Ben-Sasson SA. 1992 Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J Cell Biol, vol. 119, 493-501
36. Horwitz K., Zava D. Thilagar A., Jensen E. and Mc Guire W. 1978 Steroid receptor analysis of nine human breast cancer cell lines Cancer Res, 38, 2434-2437
37. Mauvais-Jarvis P, Sitruk-Ware R., Kuttenn F. et coll Luteal phase insufficiency a common pathophysiologic factor in development of benign and malignant breast diseases In K D Bulbrook, D J. Taylor (eds) Commentaries on research in breast diseases, vol 1 Alan R Liss. ed , New York, 1979, p.25-59
38. Sherman B. and Korenman S. 1974 Inadequate corpus luteum fonction a pathophysiological interpretation of human breast cancer epidemiology Cancer (Phila) 33, 1306-1311
39. Allan DJ, Howell A, Roberts SA et coll. 1992 Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic damage and carcinoma in the premenopausal human breast. J Pathol. vol 167, 25-32.